ATE298750T1 - 3-(heteroarylacetamido)-2-oxo-azetidin-1- sulfonsäure derivate als antibakterielle mittel - Google Patents
3-(heteroarylacetamido)-2-oxo-azetidin-1- sulfonsäure derivate als antibakterielle mittelInfo
- Publication number
- ATE298750T1 ATE298750T1 AT01980829T AT01980829T ATE298750T1 AT E298750 T1 ATE298750 T1 AT E298750T1 AT 01980829 T AT01980829 T AT 01980829T AT 01980829 T AT01980829 T AT 01980829T AT E298750 T1 ATE298750 T1 AT E298750T1
- Authority
- AT
- Austria
- Prior art keywords
- azetidine
- oxo
- heteroarylacetamido
- sulfonic acid
- acid derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23261700P | 2000-09-14 | 2000-09-14 | |
PCT/IB2001/002115 WO2002022613A1 (en) | 2000-09-14 | 2001-09-14 | 3-(heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids derivatives as antibacterial agents |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE298750T1 true ATE298750T1 (de) | 2005-07-15 |
Family
ID=22873854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01980829T ATE298750T1 (de) | 2000-09-14 | 2001-09-14 | 3-(heteroarylacetamido)-2-oxo-azetidin-1- sulfonsäure derivate als antibakterielle mittel |
Country Status (23)
Country | Link |
---|---|
US (1) | US6916803B2 (de) |
EP (1) | EP1322648B1 (de) |
JP (1) | JP2004509122A (de) |
KR (1) | KR100854810B1 (de) |
CN (1) | CN1189469C (de) |
AT (1) | ATE298750T1 (de) |
AU (2) | AU2002212614B2 (de) |
BR (1) | BR0113861A (de) |
CA (1) | CA2422375C (de) |
CZ (1) | CZ304586B6 (de) |
DE (1) | DE60111757T2 (de) |
DK (1) | DK1322648T3 (de) |
ES (1) | ES2244666T3 (de) |
HK (1) | HK1054377A1 (de) |
HU (1) | HUP0301025A3 (de) |
IL (2) | IL154593A0 (de) |
NO (1) | NO324946B1 (de) |
NZ (1) | NZ524292A (de) |
PL (1) | PL218196B1 (de) |
PT (1) | PT1322648E (de) |
SK (1) | SK2462003A3 (de) |
WO (1) | WO2002022613A1 (de) |
ZA (1) | ZA200302085B (de) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE529111T1 (de) | 2005-12-07 | 2011-11-15 | Basilea Pharmaceutica Ag | Nützliche monobactam-antibiotika |
AU2012233003B2 (en) * | 2005-12-07 | 2014-12-18 | Basilea Pharmaceutica Ag | Useful combinations of monobactam antibiotics with beta-lactamase inhibitors |
CN101641095B (zh) | 2007-03-23 | 2012-10-31 | 巴斯利尔药物股份公司 | 用于治疗细菌感染的组合药物 |
WO2009114921A1 (en) * | 2008-03-17 | 2009-09-24 | Dmitrienko Gary I | INHIBITORS OF CLASS B AND CLASS D β-LACTAMASES |
PL2603514T3 (pl) | 2010-08-10 | 2019-04-30 | Rempex Pharmaceuticals Inc | Cykliczne pochodne estrowe kwasu boronowego oraz ich zastosowania terapeutyczne |
US9012491B2 (en) | 2011-08-31 | 2015-04-21 | Rempex Pharmaceuticals, Inc. | Heterocyclic boronic acid ester derivatives and therapeutic uses thereof |
UY34585A (es) * | 2012-01-24 | 2013-09-02 | Aicuris Gmbh & Co Kg | Compuestos b-lactámicos sustituidos con amidina, su preparación y uso |
US9156858B2 (en) | 2012-05-23 | 2015-10-13 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
US10561675B2 (en) | 2012-06-06 | 2020-02-18 | Rempex Pharmaceuticals, Inc. | Cyclic boronic acid ester derivatives and therapeutic uses thereof |
CN102757405B (zh) * | 2012-07-25 | 2014-04-16 | 山东理工大学 | 含噻二唑的香兰素衍生物、其制备方法及其用途 |
US9101638B2 (en) | 2013-01-04 | 2015-08-11 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
CA2894892A1 (en) | 2013-01-04 | 2014-07-10 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
US9241947B2 (en) | 2013-01-04 | 2016-01-26 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
CN104994844A (zh) | 2013-01-04 | 2015-10-21 | 莱姆派克斯制药公司 | 硼酸衍生物及其治疗用途 |
EP3139930B1 (de) | 2014-05-05 | 2024-08-14 | Melinta Therapeutics, Inc. | Salze und polymorphe von cyclischen borsäureesterderivaten und therapeutische verwendungen davon |
PT3140310T (pt) | 2014-05-05 | 2019-11-18 | Rempex Pharmaceuticals Inc | Síntese de sais de boronato e utilizações dos mesmos |
CA2947041A1 (en) | 2014-05-19 | 2015-11-26 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
CN106536529B (zh) | 2014-07-01 | 2019-09-27 | 莱姆派克斯制药公司 | 硼酸衍生物及其治疗用途 |
US10662205B2 (en) | 2014-11-18 | 2020-05-26 | Qpex Biopharma, Inc. | Cyclic boronic acid ester derivatives and therapeutic uses thereof |
ES2761778T3 (es) | 2014-12-19 | 2020-05-21 | Rempex Pharmaceuticals Inc | Aparato y proceso de flujo continuo para la producción de derivados de ácido borónico |
WO2016149393A1 (en) | 2015-03-17 | 2016-09-22 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
US10294249B2 (en) | 2016-06-30 | 2019-05-21 | Qpex Biopharma, Inc. | Boronic acid derivatives and therapeutic uses thereof |
CN107641119B (zh) | 2016-07-21 | 2019-11-08 | 中国科学院上海药物研究所 | 单环β-内酰胺-铁载体轭合物及其制备方法和用途 |
EP3558987A1 (de) | 2016-12-21 | 2019-10-30 | AiCuris GmbH & Co. KG | Kombinationstherapie mit amidinsubstituierten ss-lactam-verbindungen und ss-lactamase-inhibitoren für infektionen mit antibiotikaresistenten bakterienstämmen |
CA3078627A1 (en) | 2017-10-11 | 2019-04-18 | Qpex Biopharma, Inc. | Boronic acid derivatives and synthesis thereof |
CN111511737B (zh) | 2018-01-29 | 2022-10-18 | 南京明德新药研发有限公司 | 用于治疗细菌感染的单环β-内酰胺化合物 |
JP7329260B2 (ja) | 2018-04-20 | 2023-08-18 | キューペックス バイオファーマ, インコーポレイテッド | ボロン酸誘導体およびその治療的使用 |
EP3901150A4 (de) | 2018-12-18 | 2022-09-07 | Medshine Discovery Inc. | Anwendung einer monocyclischen beta-lactam-verbindung in der pharmazie |
SI25892A (sl) * | 2019-09-05 | 2021-03-31 | Gorenje Gospodinjski Aparati, D.O.O. | Pralni stroj, ki se polni s sprednje strani, z električnim svetlobnim telesom |
CN114423766B (zh) | 2019-09-11 | 2024-05-17 | 丹诺医药(苏州)有限公司 | 用于治疗细菌感染的青霉烷衍生物 |
JP7446424B2 (ja) | 2019-11-22 | 2024-03-08 | スージョウ アーイェ ファーマシューティカル カンパニー リミテッド | スルホニル尿素環置換単環式β-ラクタム系抗生物質 |
CN114828850B (zh) | 2019-12-19 | 2024-08-13 | 深圳嘉科生物科技有限公司 | 化合物在制药中的应用 |
CN113754651B (zh) * | 2020-06-02 | 2023-04-18 | 中国医学科学院医药生物技术研究所 | 一种β-内酰胺化合物、其用途及其制备方法 |
CA3229556A1 (en) * | 2021-08-20 | 2023-02-23 | Marvin Miller | Conjugates of monocyclic beta-lactams and siderophore mimetics |
CN115304594B (zh) | 2022-10-12 | 2023-02-14 | 苏州二叶制药有限公司 | 磺酰脲环取代的化合物的盐型及其晶型 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4632985A (en) * | 1985-06-03 | 1986-12-30 | E. R. Squibb & Sons, Inc. | 3-acylamino-2-oxo-1-azetidinesulfonic acids |
GB8810396D0 (en) * | 1988-05-03 | 1988-06-08 | Glaxo Group Ltd | Chemical process |
US5112968A (en) | 1989-07-28 | 1992-05-12 | E. R. Squibb & Sons, Inc. | Monobactam hydrazide derivatives |
US5250691A (en) * | 1991-09-09 | 1993-10-05 | E. R. Squibb & Sons, Inc. | Heteroaryl derivatives of monocyclic beta-lactam antibiotics |
US5888998A (en) | 1997-04-24 | 1999-03-30 | Synphar Laboratories, Inc. | 2-oxo-1-azetidine sulfonic acid derivatives as potent β-lactamase inhibitors |
US5994340A (en) * | 1997-08-29 | 1999-11-30 | Synphar Laboratories, Inc. | Azetidinone derivatives as β-lactamase inhibitors |
-
2001
- 2001-09-14 IL IL15459301A patent/IL154593A0/xx active IP Right Grant
- 2001-09-14 KR KR1020037003718A patent/KR100854810B1/ko not_active IP Right Cessation
- 2001-09-14 AU AU2002212614A patent/AU2002212614B2/en not_active Ceased
- 2001-09-14 JP JP2002526866A patent/JP2004509122A/ja active Pending
- 2001-09-14 CZ CZ2003-606A patent/CZ304586B6/cs not_active IP Right Cessation
- 2001-09-14 NZ NZ524292A patent/NZ524292A/en unknown
- 2001-09-14 ZA ZA200302085A patent/ZA200302085B/en unknown
- 2001-09-14 US US10/363,222 patent/US6916803B2/en not_active Expired - Fee Related
- 2001-09-14 ES ES01980829T patent/ES2244666T3/es not_active Expired - Lifetime
- 2001-09-14 WO PCT/IB2001/002115 patent/WO2002022613A1/en active IP Right Grant
- 2001-09-14 AT AT01980829T patent/ATE298750T1/de active
- 2001-09-14 SK SK246-2003A patent/SK2462003A3/sk unknown
- 2001-09-14 PT PT01980829T patent/PT1322648E/pt unknown
- 2001-09-14 EP EP01980829A patent/EP1322648B1/de not_active Expired - Lifetime
- 2001-09-14 DK DK01980829T patent/DK1322648T3/da active
- 2001-09-14 PL PL360537A patent/PL218196B1/pl unknown
- 2001-09-14 CA CA2422375A patent/CA2422375C/en not_active Expired - Fee Related
- 2001-09-14 CN CNB018157319A patent/CN1189469C/zh not_active Expired - Fee Related
- 2001-09-14 AU AU1261402A patent/AU1261402A/xx active Pending
- 2001-09-14 BR BR0113861-8A patent/BR0113861A/pt active Search and Examination
- 2001-09-14 DE DE60111757T patent/DE60111757T2/de not_active Expired - Lifetime
- 2001-09-14 HU HU0301025A patent/HUP0301025A3/hu unknown
-
2003
- 2003-02-24 IL IL154593A patent/IL154593A/en not_active IP Right Cessation
- 2003-03-13 NO NO20031162A patent/NO324946B1/no not_active IP Right Cessation
- 2003-09-03 HK HK03106287A patent/HK1054377A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE298750T1 (de) | 3-(heteroarylacetamido)-2-oxo-azetidin-1- sulfonsäure derivate als antibakterielle mittel | |
EA200501098A1 (ru) | Антибактериальные агенты | |
DE60144392D1 (de) | Antivirale mittel | |
EA200300135A1 (ru) | Замещенные соединения матациклина (варианты), фармацевтическая композиция (варианты) и способ лечения чувствительного к тетрациклину состояния млекопитающего (варианты) | |
EA200300134A1 (ru) | Замещенные соединения тетрациклина (варианты), фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния субъекта | |
PA8486401A1 (es) | Antibioticos cetolidos carbamato y carbazato | |
EA200400086A1 (ru) | Новые производные оксазолидинонов в качестве антибактериальных агентов | |
EA200100396A1 (ru) | Новые макролидные антибиотики | |
DE69902526D1 (de) | Verbesserung der antibakteriellen wirkung von oxazolidinon durch arginin derivate | |
EA200400530A1 (ru) | Перекрестно-сшитые антибиотики "гликопептид-цефалоспорин" | |
PT1132392E (pt) | Antibioticos cetolidos | |
EA200600374A1 (ru) | Замещённые пиперидинофенилоксазолидиноны, обладающие противомикробной активностью, с повышенной in vivo эффективностью | |
NO20092655L (no) | 2-kinolinon- og 2-kinoksalinonderivater og deres anvendelse som antibakterielle midler | |
ATE205505T1 (de) | Basische oxazolinamid-derivate von ge2270 und ge2270-änlichen antibiotika | |
YU49796A (sh) | Optički aktivni derivat fenil pirimidina | |
DE69600244D1 (de) | Basische prolinamid derivate von ge2270 und ge2270-ahnlichten antibiotika | |
NO20010140L (no) | Kjemotakse-inhiberende protein av Staphylococcus (CHIPS) og dets anvendelse | |
DE602004024297D1 (de) | Carbacephem beta-lactam-antibiotika | |
DE60030300D1 (de) | Topische behandlung zur vorbeugung von augeninfektionen | |
PT1167376E (pt) | Antibioticos macrolidos | |
EA200201167A1 (ru) | Производные гигромицина а для лечения бактериальных и протозойных инфекций | |
EA200100768A1 (ru) | Применение 3-изоксазолидинонов и гидроксиаминокислот для лечения инфекций |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1322648 Country of ref document: EP |